through clinical examination and appropriate investigations (e.g. ECG, Chest X-ray, Echocardiography and other relevant investigations). Fasting serum homocysteine was measured in each patient by Fluorescence Polarization Immune-assay [FPIA] detection method. Coronary angiogram was done by right femoral artery approach. Report was reviewed by two cardiologists and CAD was assessed by Vessels score 4, 5 and Friesinger score. 6 
Results:
In this cross sectional comparative study, we have found that, out of 120 patients, the mean age was 35.4±4.2 years and 53.7±7.3 years (p=0.001) in group I and group II respectively. The gender distribution was similar in both groups with males predominating (78.3% vs 21.7% in group I and 73.3% vs 26.7% in group II), (p=0.522). Mean BMI was 24.3±7.3 kg/m 2 in group I and 25.60±8.2 kg/m 2 in group II (Table-I With normal serum homocysteine level, younger patients had more single vessel disease (SVD) or normal coronaries, but older patients even with normal homocysteine level had more double or triple vessel disease ( Table-V). With hyperhomocysteinemia, younger patients had more SVD or DVD than either TVD or normal 
Discussion:
The plasma level of homocysteine is an independent risk factor for atherosclerotic vascular disease. 5, 6 Homocysteine is present in serum as free homocysteine (1%), as a homocysteinedisulfide (10%), homocysteine-cysteine mixed disulfide (10%) or as protein-bound form (70-80%) mainly to albumin. 7 Normal total serum homocysteine concentration (tHcy) ranges from 5 to 15 µmol per liter in the fasting state. 8 Elevated serum homocysteine level is referred to as "Hyperhomocysteinemia". An abnormal total homocysteine (tHcy) is defined by an arbitrary cutoff (95th percentile), of the concentrations found in normal population. Hyperhomocysteinemia has been classified as: moderate (tHcy >15 to 30 µmol/ L), intermediate (tHcy >30 to 100 .µmol/L) and severe (tHcy >100 µmol/L) on the basis of the concentrations measured during fasting. 9 Serum homocysteine concentrations are influenced by age, gender, genetic, nutritional and acquired factors. 10 tHcy increases with age & is about 20% greater in young and middle aged men than in women of comparable age. 11 Cystathionine -synthase deficiency is the most common genetic cause of severe hyperhomocysteinemia; Nutritional deficiencies in the vitamin cofactors (folate, vitamins B6 and B12) may promote hyperhomocysteinemia. 7 Raised plasma homocysteine to be a potential risk factor for ischaemic heart disease. 12 Homocysteine accumulation could result from B-vitamin deficiency which is related to chronic immune activation. 13 Hyperhomocysteinemia is an independent risk factor for IHD in young patients especially in men and vitamin B12 deficiency is a preventable cause of hyperhomocysteinemia. 7 In our cross sectional study, we found mean serum homocysteine level was significantly higher in younger age group (15.1±8.2 mmol/L vs. 11.2±7.8 mmol/L, p=0.009). Kawashiri et al. 14 reported that plasma homocysteine level of subjects in younger IHD group was significantly higher than that of subjects in older IHD group (15.0 vs11.3 nmol/ml, p=0.03). Sadeghian et al. 15 concluded that hyperhomocysteinemia is an independent risk factor for CAD in young, especially in men.
Gender distribution in this study groups showed more male in younger IHD group (M: F= 3.6:1 in group I and 2.8:1 in group-II). This is expected because of the protective effect of female gender in premature CAD. Tewari et al. 16 observed similar sex ratio in their study.
Among the traditional risk factors, younger IHD patients had significantly higher family history of IHD (21.70% vs. 8.30%, p=0.040) and history of smoking (63.30% vs. 40.00%, p=0.011). Older patients had more hypertension (41.70% vs. 65.00%, p=0.010) and diabetes mellitus (18.30% vs. 36.70% p=0.024). Dyslipidemia was similarly higher in both groups. Schoenenberger et al. 17 mentioned that smoking, family history of CAD, dyslipidemia are important cardiovascular risk factors in young patients. Tewari et al. 16 and Majumder et al. 18 were also made the similar observations.
Mean BMI was however similar in both groups (24.3±7.3 kg/m2 vs. 25.0±8.2 kg/m2 p=0.955) and was not high in either groups. This is indicating obesity as a risk factor was not important as a whole in our patients. Pradeep et al 19 found similar BMI in their study, which are consistent with the present study. 19 Tewari et al. in their study observed mean BMI 23.7±2.42 (kg/m2) in younger group and 24.9±2.17 in older group. 16 When considering severity of CAD in younger and older groups, it was found younger patients had more normal or near normal coronary arteries (25.00% vs. 8.30%, p=0.022) or single vessel disease (48.30% vs. 25.00%, p=0.015). But older patients had more DVD (18.30% vs. 38.30%, p=0.015) and TVD (8.30% vs. 28.30%, p=0.0.004). This finding correlates well with clinical presentation of the study patients, where older patients had more MI (STEMI or NSTEMI) and younger patients had more CSA.
Raised serum homocysteine level was found in 30.00% younger IHD patients and only 13.30% older IHD patients (p=0.026). However, when considering serum homocysteine level as on CAD predisposing risk factor it was found that older patients do not show much difference in extend of CAD. They have more DVD or TVD in both normal homocysteine group (71.2%) and hyperhomocysteinemia group (62.50%). On the other hand, younger patients showed more normal coronaries in normal homocysteine group (30.90%) than in higher homocysteine group (11.10%). They have more DVD or TVD in hyperhomocysteinemia group (19.10% vs. 33.30%).
Using Friesinger score, it was seen that older patients had high Friesinger score (³5) in both normal homocysteine group (69.20%) and high homocysteine group (50.00%). But younger patients with normal homocysteine level have mostly low score (0-4) (83.30%) and mostly high Friesinger score (³5) in hyperhomocysteinemia group (61.10%). Bampi et al. observed that, Friesinger score 0 -4 indicates less extensive coronary artery disease and Friesinger score ³5 indicates extensive coronary atherosclerosis with extensive coronary artery disease. 6 These results showed that in older patient's serum homocysteine level do not correlate well with number of coronary vessels involved or with the extent of CAD. Whereas in younger patients hyperhomocysteinemia is related more to the presence of CAD and extent of CAD. In their study Tewari et al. found SVD 61.18% in group-I (younger patients) and 45.56% in group-II (older patients), DVD (23.28% vs. 32.35%) and TVD (14.61% vs. 21.3 2%). These findings were similar to our study. 16 
Conclusion:
This study showed that hyperhomcysteinemia is associated with more extensive CAD In younger IHD patients only. Whereas, in older IHD patients it does not have any significant impact on the presence or the extent of CAD. So we should routinely screen for serum homocysteine level in younger (<40 years) IHD patients. As folate and vitamin B12 supplementation can easily prevent hyperhomocysteinemia, proper diatery advice should be used to prevent premature CAD.
